Related references
Note: Only part of the references are listed.The untold burden of isolated nail psoriasis: Delayed diagnosis and significant risk of psoriatic arthritis in a retrospective study at an academic center
Michelle J. Chang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)
Luigi Gargiulo et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial
April W. Armstrong et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial
Bruce Strober et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial
Ulrich Mrowietz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)
Intralesional steroid injections for inflammatory nail dystrophies in the pediatric population
Matilde Iorizzo et al.
PEDIATRIC DERMATOLOGY (2023)
Topical Tofacitinib as Effective Therapy in Patients with Plaque Psoriasis Responsive to Systemic Drugs but with Resistant Nail Psoriasis
Rachel Berbert Ferreira et al.
SKIN APPENDAGE DISORDERS (2023)
A pilot study of intralesional methotrexate injections versus triamcinolone acetonide in patients affected by nail matrix psoriasis
Michela Starace et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)
Fungal Infections and Nail Psoriasis: An Update
Aikaterini Kyriakou et al.
JOURNAL OF FUNGI (2022)
Maintenance of response in moderate-to-severe psoriasis after withdrawal of the interleukin (IL)-17A and IL-17F nanobody sonelokimab: is there a role for IL-17F in disease reoccurrence?
Kristian Reich et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis
Marco Galluzzo et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Deucravacitinib for the Treatment of Psoriatic Disease
Ana Maria Le et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial
Bruce Strober et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
How to choose a systemic treatment for moderate-to-severe nail psoriasis
D. Rigopoulos et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3
Alexander Egeberg et al.
ACTA DERMATO-VENEREOLOGICA (2022)
Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis
Giuseppe Gallo et al.
DERMATOLOGIC THERAPY (2022)
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis The DERMIS-1 and DERMIS-2 Randomized Clinical Trials
Mark G. Lebwohl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
Angelo Ruggiero et al.
PSORIASIS-TARGETS AND THERAPY (2022)
Treatment of nail psoriasis with intramatrical methotrexate: An uncontrolled prospective study of 20 patients
Paras Choudhary et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study
K. Reich et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Small molecule inhibitors and biologics in treating nail psoriasis: A systematic review and network meta-analysis
I-Hsin Huang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs
Gurjit S. Kaeley et al.
JOURNAL OF RHEUMATOLOGY (2021)
IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
Kim A Papp et al.
LANCET (2021)
Successful management of treatment resistant nail psoriasis with tildrakizumab
Kate Simpson et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)
Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapy
A. Egeberg et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
The promise and challenges of cell therapy for psoriasis
S. M. Lwin et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Development and validation of the Physician's Global Assessment of Fingernail Psoriasis
S. Hudgens et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial
Luis Puig et al.
DERMATOLOGY AND THERAPY (2021)
The Impact of Nail Psoriasis and Treatment on Quality of Life: A Systematic Review
Claire R. Stewart et al.
SKIN APPENDAGE DISORDERS (2021)
Nail ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review
A. Fassio et al.
CLINICAL RHEUMATOLOGY (2020)
Clinical improvement in psoriatic nail disease and psoriatic arthritis with tildrakizumab treatment
Fathima F. Ismail et al.
DERMATOLOGIC THERAPY (2020)
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1)
J. L. W. Lambert et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus
Dimitrios Rigopoulos et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Nail psoriasis treated with intralesional methotrexate infiltration
Artur Antonio Duarte et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2019)
Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial
K. Reich et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Reporting of outcomes in randomized controlled trials on nail psoriasis: a systematic review
C. I. Busard et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine
Jyotisterna Mittal et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2018)
Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study
Craig Leonardi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
Kim A. Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions A Secondary Analysis of 2 Randomized Clinical Trials
Peter Foley et al.
JAMA DERMATOLOGY (2018)
Tofacitinib: A New Oral Therapy for Psoriasis
Alexandra Azevedo et al.
CLINICAL DRUG INVESTIGATION (2018)
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
Desiree van der Heijde et al.
RMD OPEN (2018)
A Case of Nail Psoriasis Successfully Treated with Intralesional Methotrexate
Sana Mokni et al.
DERMATOLOGY AND THERAPY (2018)
Identification of nail features associated with psoriasis severity
Jee Woong Choi et al.
JOURNAL OF DERMATOLOGY (2017)
Pulsed dye laser in the treatment of psoriatic nails: a controlled study
N. Y. Youssef et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3
P. van de Kerkhof et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Onychomycosis in patients with nail psoriasis: a point to point discussion
Dimitrios Rigopoulos et al.
MYCOSES (2017)
Nail findings in patients with psoriatic arthritis: A cross-sectional study with special reference to transverse grooves
Yukari Zenke et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis
Joseph F. Merola et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Role of nail bed methotrexate injections in isolated nail psoriasis: conventional drug via an unconventional route
C. Grover et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2017)
Patient-relevant needs and treatment goals in nail psoriasis
C. Blome et al.
QUALITY OF LIFE RESEARCH (2016)
Intralesional Injection for Inflammatory Nail Diseases
Ashlynne Clark et al.
DERMATOLOGIC SURGERY (2016)
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo
Daliya Banerjee et al.
IMMUNOLOGY (2016)
Laser and light therapies for the treatment of nail psoriasis
Eric L. Maranda et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis A Prospective Cohort Study
Lihi Eder et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Treatment of Nail Psoriasis Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation
Jeffrey J. Crowley et al.
JAMA DERMATOLOGY (2015)
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double- blind randomised placebo- controlled study (RAPID-PsA)
P. J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis
A. Langenbruch et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
The Impact of Fingernail Psoriasis on Patients' Health-Related and Disease-Specific Quality of Life
Haike M. J. van der Velden et al.
DERMATOLOGY (2014)
Proximal nail fold intralesional steroid injection responsible for Hoigne syndrome
R. Baran
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Nail Psoriasis, the unknown burden of disease
K. M. G. Klaassen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Quality of life and severity of skin and nail involvement in patients with plaque psoriasis
Aikaterini Kyriakou et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2014)
A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
W. C. Ports et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Comparison of nail lacquer clobetasol efficacy at 0,05%, 1% and 8% in nail psoriasis treatment: prospective, controlled and randomized pilot study
Robertha Carvalho Nakamura et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2012)
The effect of different pulse durations in the treatment of nail psoriasis with 595-nm pulsed dye laser: A randomized, double-blind, intrapatient left-to-right study
Chanitwan Treewittayapoom et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Health-Related Quality of Life in Patients with Nail Disorders
Adam Reich et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)
Nail Psoriasis Successfully Treated with Intralesional Methotrexate: Case Report
Hayriye Saricaoglu et al.
DERMATOLOGY (2011)
Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy)
M. Sanchez-Regana et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study
M. Gumusel et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Nail psoriasis in Germany: epidemiology and burden of disease
M. Augustin et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Development and validation of nail psoriasis quality of life scale (NPQ10)
J. P. Ortonne et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Evaluation of the Efficacy of Acitretin Therapy for Nail Psoriasis
Antonella Tosti et al.
ARCHIVES OF DERMATOLOGY (2009)
Treatment of Nail Psoriasis with a Two-Compound Formulation of Calcipotriol plus Betamethasone Dipropionate Ointment
D. Rigopoulos et al.
DERMATOLOGY (2009)
Association of patient-reported psoriasis severity with income and employment
Elizabeth J. Horn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: A double-blind study
Dimitris Rigopoulos et al.
ACTA DERMATO-VENEREOLOGICA (2007)
Interobserver reliability of the Nail Psoriasis Severity Index
S. Aktan et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2007)
Modification of the nail psoriasis severity index
CA Parrish et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis
P Rich et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Nail psoriasis: A combined treatment using calcipotriol cream and clobetasol propionate cream
D Rigopoulos et al.
ACTA DERMATO-VENEREOLOGICA (2002)